Ketumanpharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 21-05-2024
- Paid Up Capital ₹ 0.65 M
as on 21-05-2024
- Company Age 1 Year 7 Months
About Ketumanpharmacy
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.65 M, as per Ministry of Corporate Affairs (MCA) records.
Astha Agarwal, Sunil Kaval, Abhishek Singh, and Five other members serve as directors at the Company.
- CIN/LLPIN
U47721UP2023PTC181229
- Company No.
181229
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ketumanpharmacy?
Board Members(8)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Astha Agarwal | Director | 30-Apr-2023 | Current |
Sunil Kaval | Director | 30-Apr-2023 | Current |
Abhishek Singh | Director | 30-Apr-2023 | Current |
Shubham Dadoo | Director | 30-Apr-2023 | Current |
Vikul Kumar | Director | 30-Apr-2023 | Current |
Sandeep Garg | Director | 30-Apr-2023 | Current |
Financial Performance of Ketumanpharmacy.
Enhance accessibility to Ketumanpharmacy's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Ketumanpharmacy?
Unlock access to Ketumanpharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Nutema Health Care Private LimitedActive 11 years 9 months
Sandeep Garg and Shaleen Sharma are mutual person
- Ketumanhospital Private LimitedActive 1 year 10 months
Abhishek Singh, Shubham Dadoo and 4 more are mutual person
- Nutema Pharmacy Private LimitedActive 7 years 11 months
Sandeep Garg and Shaleen Sharma are mutual person
- Nutema Future Plus Hospital Private LimitedActive 2 years 6 months
Sandeep Garg and Shaleen Sharma are mutual person
- Kalyani Pathological Solutions Private LimitedActive 8 years 9 months
Sandeep Garg is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ketumanpharmacy?
Unlock and access historical data on people associated with Ketumanpharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ketumanpharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ketumanpharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.